NIH-funded research R01 grant

Investigating a receptor's role in abdominal aortic aneurysms

Official title: The role of protease activated receptor 2 in the initiation and progression of abdominal aortic aneurysm

Funded at University of Cincinnati · NIH-11121653 · Data updated 2026-11-12

This study is looking at how a specific protein called PAR2 affects the growth and worsening of abdominal aortic aneurysms, with the goal of finding new treatment options for patients beyond just surgery.

More Aneurysm research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Cincinnati
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startMay 15, 2025
Project endMarch 31, 2029
Funding year2025
Award (this year)$740,338
NIH project number1R01HL179626-01
Project IDNIH-11121653 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include older adults, particularly those over the age of 65, who are at higher risk for developing abdominal aortic aneurysms.

Less likely to help

Patients under the age of 65 or those without risk factors for abdominal aortic aneurysms may not benefit from this research.

What this research studies

This research focuses on understanding how protease-activated receptor 2 (PAR2) contributes to the development and worsening of abdominal aortic aneurysms (AAA). The study aims to explore the mechanisms by which PAR2 influences vascular inflammation and the behavior of specific immune cells in the aorta. By examining the effects of PAR2 on aortic health, the research seeks to identify potential new treatment options beyond surgery for patients suffering from AAA. Patients may be involved in the research to help uncover the biological pathways that lead to this serious condition.

Why it matters

Potential benefit: If successful, this research could lead to new pharmacologic treatments for abdominal aortic aneurysms, potentially reducing the need for surgical interventions.

How similar studies have gone: While the role of PAR2 in cardiovascular diseases is being explored, this specific investigation into its role in abdominal aortic aneurysms is relatively novel and has not been extensively tested.

Where this research is happening

  • University of Cincinnati
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Owens Iii, Albert Phillip — University of Cincinnati
  • Study coordinator: Owens Iii, Albert Phillip

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.